Kodiak Sciences (KOD) Other Accumulated Expenses (2017 - 2026)
Kodiak Sciences (KOD) reported Other Accumulated Expenses of $2.0 million for Q1 2026, up 116.9% on a YoY basis from $917000.0 in Q1 2025, and up 55.27% quarter-over-quarter from $1.3 million in Q4 2025.
Kodiak Sciences (KOD) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Other Accumulated Expenses for 10 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 116.9% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 116.9% YoY), and the FY2025 full-year result was $1.3 million, up 246.22% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $2.0 million, up from $1.3 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $3.0 million in Q2 2022, with the low at $343000.0 in Q3 2024.
- Historically, Other Accumulated Expenses has averaged $1.2 million across 5 years, with a median of $1.0 million in 2022.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses slumped 83.27% — and 2025, when it jumped 246.22%.
- Kodiak Sciences' Other Accumulated Expenses stood at $919000.0 in 2022, then decreased by 22.31% to $714000.0 in 2023, then tumbled by 48.18% to $370000.0 in 2024, then jumped by 246.22% to $1.3 million in 2025, then soared by 55.27% to $2.0 million in 2026.
- The last three Other Accumulated Expenses figures came in at $2.0 million (Q1 2026), $1.3 million (Q4 2025), and $496000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Kodiak Sciences | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 496,000.00 |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 917,000.00 |
| Dec 31, 2024 | 370,000.00 |
| Sep 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 456,000.00 |
| Mar 31, 2024 | 953,000.00 |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 919,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 2.96 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 715,000.00 |
| Sep 30, 2021 | 797,000.00 |
| Jun 30, 2021 | 2.43 Mn |